Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2026)

Neuroone Medical Technologies (NMTC) has reported Inventory Average for 6 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 17.61% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at $2.2 million (up 17.61% YoY), and the FY2025 full-year result was $2.4 million, up 11.47% from the prior year.
• Inventory Average rose to $2.2 million in Q2 2026 per NMTC's latest filing, from $1.9 million in the prior quarter.
• Across five years, Inventory Average topped out at $2.3 million in Q4 2024 and bottomed at $225509.0 in Q1 2022.
• Historically, Inventory Average has averaged $1.5 million across 5 years, with a median of $1.6 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 670.14% in 2022, then fell 14.74% in 2025.
• Over 5 years, Inventory Average stood at $804046.0 in 2022, then surged by 107.41% to $1.7 million in 2023, then surged by 36.9% to $2.3 million in 2024, then dropped by 14.74% to $1.9 million in 2025, then grew by 12.76% to $2.2 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $2.2 million, $1.9 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.